دورية أكاديمية

Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells

التفاصيل البيبلوغرافية
العنوان: Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
المؤلفون: Colucci, Manuel, Zumerle, Sara, Bressan, Silvia, Gianfanti, Federico, Troiani, Martina, Valdata, Aurora, D’Ambrosio, Mariantonietta, Pasquini, Emiliano, Varesi, Angelica, Cogo, Francesca, Mosole, Simone, Dongilli, Cristina, Desbats, Maria Andrea, Contu, Liliana, Revankdar, Ajinkya, Chen, Jingjing, Kalathur, Madhuri, Perciato, Maria Luna, Basilotta, Rossella, Laczko, Endre, Schauer, Stefan, Othman, Alaa, id_orcid:0 000-0002-0092-5594
المصدر: Cancer Cell, 42 (4)
بيانات النشر: Cell Press
سنة النشر: 2024
المجموعة: ETH Zürich Research Collection
مصطلحات موضوعية: senescence, prostate cancer, SASP, immunotherapy, RAR, adapalene, AP-1, metabolism, NK-Killing, allogenic infusion
الوصف: Cellular senescence can exert dual effects in tumors, either suppressing or promoting tumor progression. The senescence-associated secretory phenotype (SASP), released by senescent cells, plays a crucial role in this dichotomy. Consequently, the clinical challenge lies in developing therapies that safely enhance senescence in cancer, favoring tumor-suppressive SASP factors over tumor-promoting ones. Here, we identify the retinoic-acid-receptor (RAR) agonist adapalene as an effective pro-senescence compound in prostate cancer (PCa). Reactivation of RARs triggers a robust senescence response and a tumor-suppressive SASP. In preclinical mouse models of PCa, the combination of adapalene and docetaxel promotes a tumor-suppressive SASP that enhances natural killer (NK) cell-mediated tumor clearance more effectively than either agent alone. This approach increases the efficacy of the allogenic infusion of human NK cells in mice injected with human PCa cells, suggesting an alternative therapeutic strategy to stimulate the anti-tumor immune response in “immunologically cold” tumors. ; ISSN:1535-6108 ; ISSN:1878-3686
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/application/pdf
اللغة: English
العلاقة: http://hdl.handle.net/20.500.11850/668544Test
DOI: 10.3929/ethz-b-000668544
الإتاحة: https://doi.org/20.500.11850/668544Test
https://doi.org/10.3929/ethz-b-000668544Test
https://doi.org/10.1016/j.ccell.2024.02.004Test
https://hdl.handle.net/20.500.11850/668544Test
حقوق: info:eu-repo/semantics/openAccess ; http://creativecommons.org/licenses/by-nc/4.0Test/ ; Creative Commons Attribution-NonCommercial 4.0 International
رقم الانضمام: edsbas.624C2AD4
قاعدة البيانات: BASE